Submitted by Anonymous (not verified) on 4 August 2023 - 12:06
Human medicines European public assessment report (EPAR): Busilvex, busulfan, Hematopoietic Stem Cell Transplantation, Date of authorisation: 09/07/2003, Revision: 19, Status: Withdrawn
Source: